Please use this identifier to cite or link to this item:
|Title:||Effects of antileukotriene among asthmatic patients|
|Citation:||Journal of the Medical Association of Thailand. Vol.84, No.5 (2001), 719-722|
|Abstract:||Study objective: To determine the effect of antileukotriene (montelukast) 10 mg once daily for the treatment of mild to moderate asthma. Design: Open label, prospective. Patients: Thirty asthmatic patients ≥18 years of age with baseline FEV1>60 per cent and ≤80 per cent of predicted values and evidence of reversible airway obstruction, as defined by an increase in FEV1 of ≥20 per cent. Interventions: Montelukast 10 mg once daily orally for 12 weeks, back up beta-2 agonist inhaler was available. Measurement and results: Spirometry was performed during the screening period, and every month after starting antileukotriene. Subjects recorded asthma-related symptoms and use of supplement beta-2 agonists daily on diary cards. Over 12 weeks of treatment, the FEV1 increased 10 per cent, 14 per cent and 19 per cent respectively, compared to the baseline (p<0.05). The physician and patients evaluation scores were quite good in the study. Conclusion: Oral montelukast once daily gave a favorable effect in management of mild to moderate asthmatic patients.|
|Appears in Collections:||Scopus 2001-2005|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.